Publication:
The Application and Interpretation of IgG Avidity and IgA ELISA Tests to Characterize Zika Virus Infections

dc.contributor.authorAmaro, Fatima
dc.contributor.authorSánchez-Seco, María Paz
dc.contributor.authorVazquez, Ana
dc.contributor.authorAlves, Maria J
dc.contributor.authorZé-Zé, Líbia
dc.contributor.authorLuz, Maria T
dc.contributor.authorMinguito, Teodora
dc.contributor.authorFuente, Jesus de la
dc.contributor.authorDe Ory, Fernando de
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2020-01-29T11:46:59Z
dc.date.available2020-01-29T11:46:59Z
dc.date.issued2019
dc.description.abstractIn the absence of viremia, the diagnostics of Zika virus (ZIKV) infections must rely on serological techniques. In order to improve the serological diagnosis of ZIKV, ZIKV-IgA and ZIKV-IgG avidity assays were evaluated. Forty patients returning from ZIKV endemic areas, with confirmed or suspected ZIKV infections were studied. Samples were classified as early acute, acute and late acute according to the number of days post illness onset. Low avidity IgG was only detected at acute and late acute stages and IgA mostly at the early acute and acute stages. The date of sampling provides useful information and can help to choose the best technique to use at a determined moment in time and to interpret low avidity IgG and IgA results, improving the serological diagnosis of ZIKV.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work has been partially funded by the ISCIII Project “PI16CIII/00037”.es_ES
dc.format.number2es_ES
dc.format.page179es_ES
dc.format.volume11es_ES
dc.identifier.citationViruses. 2019 Feb 20;11(2). pii: E179.es_ES
dc.identifier.doi10.3390/v11020179es_ES
dc.identifier.e-issn1999-4915es_ES
dc.identifier.issn1999-4915es_ES
dc.identifier.journalViruseses_ES
dc.identifier.pubmedID30791664es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8971
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI16CIII/00037es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/v11020179es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectIgAes_ES
dc.subjectIgG avidity testses_ES
dc.subjectZika viruses_ES
dc.subjectCross-reactionses_ES
dc.subjectDengue viruses_ES
dc.subjectSecondary infectionses_ES
dc.subject.meshCross Reactionses_ES
dc.subject.meshData Interpretation, Statisticales_ES
dc.subject.meshDisease Outbreakses_ES
dc.subject.meshHumanses_ES
dc.subject.meshImmunoglobulin Aes_ES
dc.subject.meshImmunoglobulin Ges_ES
dc.titleThe Application and Interpretation of IgG Avidity and IgA ELISA Tests to Characterize Zika Virus Infectionses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication6bbc845c-9a07-4f09-95c5-4f9e52cc9f18
relation.isAuthorOfPublication66b278e7-6c3a-44aa-96a9-f3a70a6c9dcf
relation.isAuthorOfPublication9be5c5fe-643b-4e8e-91b9-8938245796a5
relation.isAuthorOfPublication26a56bc6-4e8c-457c-8999-13fd4d2bed1a
relation.isAuthorOfPublication588bf125-2873-4148-b3db-979db601b3c7
relation.isAuthorOfPublication3934227c-f6db-420f-b986-334b16d5221a
relation.isAuthorOfPublication.latestForDiscovery6bbc845c-9a07-4f09-95c5-4f9e52cc9f18
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
TheApplicationAndInterpretation_2019.pdf
Size:
409.51 KB
Format:
Adobe Portable Document Format
Description: